HRTS holdings
Tema Heart & Health ETF
Positions
45 stored of 45 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 532457108 | 11.521% | $6.0M | Equity (common) | Corporate | United States | USD |
| 2 | UnitedHealth Group Inc | US91324P1021 | 91324P102 | 5.244% | $2.7M | Equity (common) | Corporate | United States | USD |
| 3 | Novo Nordisk A/S | DK0062498333 | Not reported | 5.236% | $2.7M | Equity (common) | Corporate | Denmark | DKK |
| 4 | Roche Holding AG | US7711951043 | 771195104 | 4.495% | $2.3M | Equity (common) | Corporate | Switzerland | USD |
| 5 | Merck & Co Inc | US58933Y1055 | 58933Y105 | 4.270% | $2.2M | Equity (common) | Corporate | United States | USD |
| 6 | AstraZeneca PLC | GB0009895292 | Not reported | 4.002% | $2.1M | Equity (common) | Corporate | United Kingdom | GBP |
| 7 | Thermo Fisher Scientific Inc | US8835561023 | 883556102 | 3.970% | $2.1M | Equity (common) | Corporate | United States | USD |
| 8 | Johnson & Johnson | US4781601046 | 478160104 | 3.591% | $1.9M | Equity (common) | Corporate | United States | USD |
| 9 | Gilead Sciences Inc | US3755581036 | 375558103 | 3.434% | $1.8M | Equity (common) | Corporate | United States | USD |
| 10 | Novartis AG | CH0012005267 | Not reported | 3.381% | $1.8M | Equity (common) | Corporate | Switzerland | CHF |
| 11 | Revolution Medicines Inc | US76155X1000 | 76155X100 | 3.328% | $1.7M | Equity (common) | Corporate | United States | USD |
| 12 | Vertex Pharmaceuticals Inc | US92532F1003 | 92532F100 | 2.929% | $1.5M | Equity (common) | Corporate | United States | USD |
| 13 | Danaher Corp | US2358511028 | 235851102 | 2.659% | $1.4M | Equity (common) | Corporate | United States | USD |
| 14 | Abbott Laboratories | US0028241000 | 002824100 | 2.607% | $1.4M | Equity (common) | Corporate | United States | USD |
| 15 | Bridgebio Pharma Inc | US10806X1028 | 10806X102 | 2.594% | $1.3M | Equity (common) | Corporate | United States | USD |
| 16 | Cytokinetics Inc | US23282W6057 | 23282W605 | 2.524% | $1.3M | Equity (common) | Corporate | United States | USD |
| 17 | AbbVie Inc | US00287Y1091 | 00287Y109 | 2.396% | $1.2M | Equity (common) | Corporate | United States | USD |
| 18 | Bristol-Myers Squibb Co | US1101221083 | 110122108 | 2.086% | $1.1M | Equity (common) | Corporate | United States | USD |
| 19 | Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd | US8816242098 | 881624209 | 2.060% | $1.1M | Equity (common) | Corporate | Israel | USD |
| 20 | Dexcom Inc | US2521311074 | 252131107 | 1.919% | $996K | Equity (common) | Corporate | United States | USD |
| 21 | Amgen Inc | US0311621009 | 031162100 | 1.911% | $992K | Equity (common) | Corporate | United States | USD |
| 22 | Medtronic PLC | IE00BTN1Y115 | Not reported | 1.877% | $975K | Equity (common) | Corporate | Ireland | USD |
| 23 | Edwards Lifesciences Corp | US28176E1082 | 28176E108 | 1.747% | $907K | Equity (common) | Corporate | United States | USD |
| 24 | McKesson Corp | US58155Q1031 | 58155Q103 | 1.710% | $888K | Equity (common) | Corporate | United States | USD |
| 25 | Regeneron Pharmaceuticals Inc | US75886F1075 | 75886F107 | 1.667% | $866K | Equity (common) | Corporate | United States | USD |
| 26 | Madrigal Pharmaceuticals Inc | US5588681057 | 558868105 | 1.455% | $755K | Equity (common) | Corporate | United States | USD |
| 27 | Boston Scientific Corp | US1011371077 | 101137107 | 1.422% | $738K | Equity (common) | Corporate | United States | USD |
| 28 | Chugai Pharmaceutical Co Ltd | JP3519400000 | Not reported | 1.328% | $690K | Equity (common) | Corporate | Japan | JPY |
| 29 | Intuitive Surgical Inc | US46120E6023 | 46120E602 | 1.301% | $675K | Equity (common) | Corporate | United States | USD |
| 30 | Alnylam Pharmaceuticals Inc | US02043Q1076 | 02043Q107 | 1.137% | $590K | Equity (common) | Corporate | United States | USD |
| 31 | Arrowhead Pharmaceuticals Inc | US04280A1007 | 04280A100 | 1.087% | $564K | Equity (common) | Corporate | United States | USD |
| 32 | Scholar Rock Holding Corp | US80706P1030 | 80706P103 | 0.916% | $476K | Equity (common) | Corporate | United States | USD |
| 33 | Xenon Pharmaceuticals Inc | CA98420N1050 | 98420N105 | 0.885% | $459K | Equity (common) | Corporate | Canada | USD |
| 34 | Ionis Pharmaceuticals Inc | US4622221004 | 462222100 | 0.825% | $428K | Equity (common) | Corporate | United States | USD |
| 35 | Insulet Corp | US45784P1012 | 45784P101 | 0.791% | $411K | Equity (common) | Corporate | United States | USD |
| 36 | Ascendis Pharma A/S | DK0060615755 | Not reported | 0.758% | $393K | Equity (common) | Corporate | Denmark | USD |
| 37 | First American Treasury Obliga First American Treasury Obligations Fund | US31846V3289 | 31846V328 | 0.719% | $373K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 38 | Insmed Inc | US4576693075 | 457669307 | 0.710% | $369K | Equity (common) | Corporate | United States | USD |
| 39 | Stoke Therapeutics Inc | US86150R1077 | 86150R107 | 0.598% | $311K | Equity (common) | Corporate | United States | USD |
| 40 | Viking Therapeutics Inc | US92686J1060 | 92686J106 | 0.538% | $280K | Equity (common) | Corporate | United States | USD |
| 41 | MBX Biosciences Inc | US55287L1017 | 55287L101 | 0.531% | $276K | Equity (common) | Corporate | United States | USD |
| 42 | Zealand Pharma A/S | DK0060257814 | Not reported | 0.517% | $268K | Equity (common) | Corporate | Denmark | DKK |
| 43 | Gubra A/S | DK0062266474 | Not reported | 0.482% | $250K | Equity (common) | Corporate | Denmark | DKK |
| 44 | Intellia Therapeutics Inc | US45826J1051 | 45826J105 | 0.376% | $195K | Equity (common) | Corporate | United States | USD |
| 45 | Structure Therapeutics Inc | US86366E1064 | 86366E106 | 0.347% | $180K | Equity (common) | Corporate | United States | USD |